February 2, 2016 – The Institute for Clinical and Economic Review (ICER) announced today that it will develop a report assessing the comparative effectiveness and value of diabetes prevention programs. The report will be the subject of the June 24, 2016 public meeting of the California Technology Assessment Forum (CTAF). ICER’s report will include a […]
Read More
02/02/2016
Boston, Mass., July 25, 2016– The Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report and Meeting Summary titled Diabetes Prevention Programs: Comparative Clinical Effectiveness and Value. The Final Report reviews the comparative clinical effectiveness and value of CDC-recognized diabetes prevention programs (DPPs) and provides an in-depth review of the policy […]
Read More
07/25/2016
Boston, Mass., March 18, 2016 — The Institute for Clinical and Economic Review (ICER) has appointed eight new members to the New England Comparative Effectiveness Public Advisory Council (New England CEPAC). Including the new members, the New England CEPAC is composed of 22 New England-based experts who represent a broad range of perspectives including medical […]
Read More
03/18/2016
The Institute for Clinical and Economic Review (ICER) has released the slate of new drugs it plans to review in 2016. These reviews are a continuation of the new drug assessment program begun in the Fall of 2015. The list of drugs to be reviewed is based on ICER’s discussion with multiple payers and other […]
Read More
11/19/2015
The Institute for Clinical and Economic Review (ICER) has released the slate of new drugs it plans to review in 2016. These reviews are a continuation of the new drug assessment program begun in the Fall of 2015. The list of drugs to be reviewed is based on ICER’s discussion with multiple payers and other […]
Read More
11/19/2015
Independent panel members debate the evidence on the effectiveness and value of new drugs and other health care interventions at ICER public meetings Boston, Mass., November 2, 2016 – The Institute for Clinical and Economic Review (ICER) is seeking nominations for new members to join its leading independent evidence review groups: The California Technology Assessment […]
Read More
11/02/2016
Public Comments
Closed